题名 | Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC) |
链接 | http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/LBA109 |
http://meeting.ascopubs.org/cgi/ ... /33/15_suppl/LBA109
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |